Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Lung Neoplasms 3Peripheral Nervous System Diseases 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Infections 1Healthy Subject 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Fish Oils × Clear all
NCT02534389 2017-02-09

Fish Oil Supplement in Rectal Cancer

AC Camargo Cancer Center

Phase NA Completed
100 enrolled
Gastrointestinal

Inflammation, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡